may influence Parkinson's disease
[PMID 19573950] GSK3beta polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort
abstract may influence brain structure
[PMID 20039940] Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3beta) on the risk of Parkinson's disease
[PMID 20605420] Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians
[PMID 20055739] Role of glycogen synthase kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus
[PMID 21159074] SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study
[PMID 16315267] GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
[PMID 19581563] Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
[PMID 21527318] GSK3beta genetic variability in patients with Multiple Sclerosis.
[PMID 23021822] Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium
[PMID 21130530] Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India
[PMID 23525328] Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
[PMID 23030648] Possible association of the GSK3beta gene with the anxiety symptoms of major depressive disorder and P300 waveform.
[PMID 23628795] The association between glycogen synthase kinase 3 beta polymorphisms and Parkinson's disease susceptibility: a meta-analysis.